Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2t. Annual reported cases of notifiable diseases, by region and reporting area, United States and U.S. Territories, excluding Non-U.S. Residents*, 2019
Data from some jurisdictions may be incomplete due to the coronavirus disease 2019 (COVID-19) pandemic. Please see Note #9 at the bottom of the table.
Reporting Area Yellow fever Zika virus
Zika virus disease, congenital § Zika virus disease, non-congenital Zika virus infection, congenital § Zika virus infection, non-congenital
U.S. Residents, excluding U.S. Territories 28 177
New England
Connecticut
Maine
Massachusetts
New Hampshire
Rhode Island
Vermont
Middle Atlantic 8 27
New Jersey 4 8
New York (excluding New York City) 1 8
New York City 3 10
Pennsylvania 1
East North Central
Illinois
Indiana
Michigan
Ohio
Wisconsin
West North Central 4 2
Iowa 1
Kansas
Minnesota 3 1
Missouri
Nebraska 1
North Dakota
South Dakota
South Atlantic 4 77
Delaware
District of Columbia
Florida 39
Georgia 2 4
Maryland 1 5
North Carolina 2
South Carolina
Virginia 1 27
West Virginia
East South Central 2
Alabama
Kentucky 2
Mississippi
Tennessee
West South Central 2 26
Arkansas
Louisiana 1
Oklahoma
Texas 2 25
Mountain 4 6
Arizona
Colorado
Idaho N 1
Montana
Nevada 1
New Mexico
Utah 2 6
Wyoming
Pacific 6 37
Alaska
California 5 35
Hawaii
Oregon 1
Washington 2
U.S. Territories 74 35
American Samoa
Commonwealth of Northern Mariana Islands
Guam
Puerto Rico 74 35
U.S. Virgin Islands
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * The 2019 annual tables exclude cases of nationally notifiable conditions and diseases among non-U.S. residents. As a result, data in Table 2 does not include a "Non-U.S. Resident" or "Total" row, that would have been included in the table had the data been stratified into the following four categories, based upon the "country of usual residence" (COUR) algorithm: U.S. Residents, excluding U.S. Territories; U.S. Territories; Non-US. Residents; and Total.Table 2 for the 2019 annual tables only includes the first two of these stratification categories.
  • † To calculate rates, use the populations provided in Table 8. Note that calculation of rates for the following conditions use population subsets presented in Table 8: Zika virus infection, congenital; Zika virus disease, congenital; Infant botulism; Congenital rubella syndrome; Perinatal Hepatitis B infection, Perinatal Hepatitis C infection, Haemophilus influenzae, invasive disease and Invasive pneumococcal disease, and Influenza associated pediatric mortality; see Table 8 (population reference table). Also see notes 3 and 7.
  • § Data reported to ArboNET using the national surveillance case definition for congenital Zika virus infection (CSTE Position Statement 16-ID-01).